We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App




New Version of 3-Part Differential Hematology Analyzer Launched

By LabMedica International staff writers
Posted on 08 Apr 2014
Print article
Image: The Abacus 3CT hematology analyzer, a compact, bench-top, flexible 3-part differential analyzer (Photo courtesy of the Diatron Group).
Image: The Abacus 3CT hematology analyzer, a compact, bench-top, flexible 3-part differential analyzer (Photo courtesy of the Diatron Group).
A new hematology analyzer is particularly suitable for small laboratories, satellite clinics, and doctors’ offices.

Launched by the Diatron Group (Budapest, Hungary) the new Abacus 3CT hematology analyzer is a compact, bench-top, flexible 3-part differential analyzer. It offers 22 parameters thus delivering more patient data, and has a cap piercing capability that enables it to be used with sample tubes that are open or closed.

The new analyzer has been enhanced significantly from the original version. The most visually apparent changes are the introduction of the latest 8” high resolution and the color touch screen with new intuitive multilingual user interface, which makes it clear and simple to operate.

The new Abacus 3CT has an enhanced package of on-board quality control (QC) features. The QC capacity has been greatly increased to 24 lots, and QC values can now be loaded via QR codes or USB to avoid any incorrect assignment of values. Operating rights can also be assigned to selected operators to ensure that only trained persons can use the system. In addition, an on-board log details when reagents were last changed, with a constant on-screen display of reagent expiry dates as well as remaining reagent volumes. Other QC features include aperture anticlog protection and automatic cleaning after every 15 sample measurements.

To accommodate the increased volume of data generated by the 22 parameter measurements, the on-board data storage capacity of the Abacus 3CT has been doubled to 10,000 records, with improved laboratory information system (LIS) connectivity for results transfer.

Diatron develops, manufactures, and markets hematology and clinical chemistry analyzers, and associated reagents for human medical and veterinary use. An R&D/engineering team develops and manufactures a broad product range of products including: hematology analyzers, hematology reagents (both for its own and other manufacturers’ analyzers), hematology control material, clinical chemistry analyzers, clinical chemistry reagents, and clinical chemistry controls.

Related Links:

Diatron Group


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.